Notícias do Mercado de Ações
Últimas notícias financeiras · Atualizado Jul 15, 2026
RTX (RTX) Demonstra Sistema de Comunicações de Combate de Autocura PACE4ACE
RTX (RTX) Demonstrates Self-Healing Combat Communications System PACE4ACE
The panel generally views RTX's PACE4ACE demo as a technical achievement but expresses skepticism about its near-term impact on RTX's …
A 1 Ação de Tecnologia que Acredito Ter Mais Potencial de Valorização do que Qualquer Outra no S&P 500 Neste Momento
The 1 Tech Stock I Think Has More Upside Than Anything Else in the S&P 500 Right Now
The panel consensus is bearish on MercadoLibre (MELI), citing concerns about macroeconomic volatility in Latin America, intense competition, and the …
Philip Morris (PM) Nomeia Massimo Andolina como CFO do Grupo
Philip Morris (PM) Appoints Massimo Andolina as Group CFO
The panelists have mixed views on Philip Morris' appointment of Massimo Andolina as CFO. While some see it as a …
A Exxon Mobil (XOM) é uma das Melhores Ações de Baixo Risco para Comprar em 2026?
Is Exxon Mobil (XOM) One of the Best Low Risk Stocks to Buy in 2026?
Despite operational wins like Guyana's record production and LNG exports, Exxon's (XOM) 'low risk' label is disputed due to earnings …
Aqui está o porquê The Home Depot (HD) é uma das Melhores Ações de Baixo Risco para Comprar em 2026
Here is Why The Home Depot (HD) is One of the Best Low Risk Stocks to Buy in 2026
The panel largely agrees that Home Depot's current performance and guidance signal stability rather than growth, with key risks including …
Outra companhia aérea declara falência e cancela todos os voos
Another airline files for bankruptcy and cancels all flights
The discussion reveals a mixed view on the impact of recent airline bankruptcies, with some participants arguing that it signals …
Merck (MRK) Fase 3 do Ensaio TroFuse-005 para Câncer de Endométrio Atende aos Pontos Finais Primários
Merck (MRK) Phase 3 TroFuse-005 Trial for Endometrial Cancer Meets Primary Endpoints
Merck's TroFuse-005 Phase 3 win in endometrial cancer is a significant achievement but may not substantially impact enterprise value until …
Qualcomm vs. Intel: O que as Tendências Recentes de Receita Dizem aos Investidores
Qualcomm vs. Intel: What Recent Revenue Trends Tell Investors
The panel's net takeaway is that while Intel's revenue growth and AI partnerships are promising, its margin pressure and potential …
Por que a American Express Ainda é uma Ação Top de Buffett Depois de Todos Esses Anos
Why American Express Is Still a Top Buffett Stock After All These Years
The panel's net takeaway is that American Express (AXP) faces significant cyclical risks and potential headwinds, despite its closed-loop advantages …
Conversões Roth Nem Sempre Compensam: 3 Sinais de Que é a Decisão Errada Para Você
Roth Conversions Don't Always Pay: 3 Signs It's the Wrong Move for You
The panel agreed that Roth conversions can be beneficial, but the optimal strategy depends on individual circumstances, including income, tax …
Melhor Ação Financeira de Alto Rendimento: AGNC Investment vs. Annaly Capital
Better High-Yield Financial Stock: AGNC Investment vs. Annaly Capital
The panel consensus is bearish on AGNC and Annaly (NLY), warning that these mortgage REITs, despite their high yields, are …
O Ações da NIQ Global Intelligence São uma Compra Após o CEO Adquirir Ações no Valor de US$ 1 Milhão?
Is NIQ Global Intelligence Stock a Buy After Its CEO Purchased Shares Worth $1 Million?
Despite CEO Peck's insider buying, the panel remains overwhelmingly bearish due to persistent losses, limited cost-saving targets, and significant debt …